Innovent Biologics: Revenue growth of more than 50% and market value hit a new high
Innovent Biologics: Revenue growth of more than 50% and market value hit a new high
2025-03-28 06:51:53
Hengrui Pharmaceutical: Obtained the "Notice of Approval of Drug Clinical Trials"
Hengrui Pharmaceutical: Obtained the "Notice of Approval of Drug Clinical Trials"
2025-03-27 08:53:51
Hengrui Pharmaceutical: Subsidiary obtained the "Notice of Approval of Drug Clinical Trial"
Hengrui Pharmaceutical: Subsidiary obtained the "Notice of Approval of Drug Clinical Trial"
2025-03-26 18:04:38